1. Home
  2. ARDX vs DMLP Comparison

ARDX vs DMLP Comparison

Compare ARDX & DMLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ardelyx Inc.

ARDX

Ardelyx Inc.

HOLD

Current Price

$6.21

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

DMLP

Dorchester Minerals L.P.

HOLD

Current Price

$27.86

Market Cap

1.3B

Sector

Energy

ML Signal

HOLD

Company Overview

Basic Information
Metric
ARDX
DMLP
Founded
2007
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Oil & Gas Production
Sector
Health Care
Energy
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.3B
IPO Year
2014
2002

Fundamental Metrics

Financial Performance
Metric
ARDX
DMLP
Price
$6.21
$27.86
Analyst Decision
Strong Buy
Analyst Count
7
0
Target Price
$15.14
N/A
AVG Volume (30 Days)
3.0M
177.6K
Earning Date
04-30-2026
05-07-2026
Dividend Yield
N/A
10.06%
EPS Growth
N/A
N/A
EPS
N/A
1.16
Revenue
$2,607,000.00
$152,832,000.00
Revenue This Year
$37.75
N/A
Revenue Next Year
$34.24
N/A
P/E Ratio
N/A
$23.99
Revenue Growth
N/A
N/A
52 Week Low
$3.50
$20.85
52 Week High
$8.40
$29.95

Technical Indicators

Market Signals
Indicator
ARDX
DMLP
Relative Strength Index (RSI) 56.13 57.75
Support Level $5.49 $27.21
Resistance Level $6.23 N/A
Average True Range (ATR) 0.24 0.69
MACD 0.10 -0.07
Stochastic Oscillator 94.53 63.77

Price Performance

Historical Comparison
ARDX
DMLP

About ARDX Ardelyx Inc.

Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. Its products Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.

About DMLP Dorchester Minerals L.P.

Dorchester Minerals LP operates as the owner of producing and non-producing crude oil and natural gas mineral, royalty, overriding royalty, net profits, and leasehold interests. The company generates revenues from royalties, net profits interests, lease bonuses, and others.

Share on Social Networks: